查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1584092

心包膜穿刺术市场，按适应症、按疾病类型、按最终用户、按国家和地区 - 2024-2032 年的行业分析、市场规模、市场份额和预测

Pericardiocentesis Procedures Market, By Indication, By Disease Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年心包膜穿刺术市场规模为 1.8109 亿美元，2024 年至 2032 年复合年增长率为 3.29%。

心包膜穿刺术市场-市场动态

心血管疾病盛行率不断上升，癌症治疗方法不断增加，早期诊断预计将推动市场需求

心包膜炎、心臟衰竭和心包膜积液等心血管疾病的发生率不断上升，增加了对心包膜穿刺术作为治疗选择的需求，从而促进了市场成长。心臟压迫需要紧急心包穿刺术来缓解。超音波和超音波心动图等影像技术的改进使心包穿刺术更加准确和安全，从而提高了采用率。这些影像工具对于指导手术过程至关重要。

对心包积液及其併发症的更多认识有助于更早发现和介入。再加上诊断能力的提高，推动了对心包膜穿刺术等手术的需求。某些癌症治疗，例如化疗和放疗，可能会导致心包膜积水的副作用。这导致癌症患者，尤其是晚期疾病患者对心包膜穿刺术的需求增加。心包膜穿刺术导管疗法的技术进步，包括针头设计、导管技术和引流系统的改进，使手术更加高效、安全，从而促进了其采用并支持市场成长。

心包膜穿刺术市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 3.29% 左右的复合年增长率成长

根据适应症细分，由于癌症的高盛行率，预计恶性肿瘤细分市场将在 2023 年显示最大的市场份额。

根据疾病类型细分，由于心臟病的增加，肺癌细分市场成为 2023 年主要的疾病类型细分市场。

根据最终用户细分，由于需要诊断晚期癌症、结核病等，医院和诊所细分市场是 2023 年领先的最终用户细分市场。

按地区划分，由于心血管疾病的高发生率，北美将成为 2023 年的主要收入来源。

心包膜穿刺术市场細項分析：

全球心包膜穿刺术市场根据适应症、疾病类型、最终用户和地区进行细分。

市场依适应症分为五类：感染、恶性肿瘤、心臟、发炎等。恶性肿瘤细分市场占据主导地位。转移性肿瘤发生率的增加主要是促进了节段的生长。

市场依疾病类型分为四类：肺癌、乳癌、淋巴瘤等。肺癌细分市场占据主导地位。心臟骤停和肺部疾病发生率的增加正在促进市场需求。

根据最终用户，市场分为三类：医院和诊所、心臟中心等。医院和诊所领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。狼疮、类风湿性关节炎和硬皮症等慢性免疫疾病的流行正在推动该细分市场的成长。

心包膜穿刺术市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。在北美，美国和加拿大是主要贡献者，其中美国在程序数量和创新方面处于领先地位。受人口老化和心血管疾病发病率上升的推动，欧洲是另一个重要市场。在亚太地区，人们对心包膜积水和心臟病的认识和早期诊断不断提高。中国、日本和印度是该地区的主要市场，导致心包穿刺术的需求不断增长。

心包膜穿刺术市场-竞争格局：

心包膜穿刺术市场竞争激烈，主要参与者包括美敦力 (Medtronic)、波士顿科学 (Boston Scientific)、BD 和库克医疗 (Cook Medical)，这些公司专注于技术创新和产品开发。公司正在根据医疗保健提供者和患者群体的具体需求提供客製化的心包穿刺套件，以确保该过程尽可能有效和高效。该公司正在开发下一代导管和引流系统，以提高心包膜穿刺术的安全性、精确度和舒适度。

2022 年，泰利福公司推出了专门的导管和针头系统，用于从心包腔排出液体。

2022年，库克医疗宣布推出多种诊断和介入设备，包括心包穿刺套件和配件。

目录

第 1 章：心包膜穿刺术市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 依适应症分類的心包膜穿刺术市场片段
    • 依疾病类型分類的心包膜穿刺术市场片段
    • 最终用户的心包穿刺术市场片段
    • 按国家/地区分類的心包穿刺术市场片段
    • 按地区分類的心包膜穿刺术市场片段
  • 竞争洞察

第 3 章：心包膜穿刺术主要市场趋势

  • 心包膜穿刺术市场驱动因素
    • 市场驱动因素的影响分析
  • 心包膜穿刺术市场限制
    • 市场限制影响分析
  • 心包膜穿刺术市场机会
  • 心包膜穿刺术市场未来趋势

第 4 章：心包膜穿刺术产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：心包膜穿刺术市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：心包膜穿刺术市场格局

  • 2023 年心包膜穿刺术市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：心包膜穿刺术市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 感染
    • 恶性肿瘤
    • 心臟
    • 发炎
    • 其他的

第 8 章：心包膜穿刺术市场 - 依疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 肺癌
    • 乳癌
    • 淋巴瘤
    • 其他的

第 9 章：心包膜穿刺术市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院及诊所
    • 心臟中心
    • 其他的

第 10 章：心包膜穿刺术市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美心包穿刺术主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲心包穿刺术主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区心包膜穿刺术主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲心包膜穿刺术主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲心包膜穿刺术主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 心包膜穿刺术产业

  • 竞争仪表板
  • 公司简介
    • Boston Scientific Corporation
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Cook Medical Inc.
    • CR Bard Inc.
    • Merit Medical Systems Inc.
    • Teleflex Incorporated
    • Cardinal Health Inc.
    • Johnson & Johnson Services Inc.
    • AngioDynamics Inc.
    • Medtronic
    • Smith's Medical
    • BD
    • Edwards Lifesciences
    • Stryker Corporation
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4082

REPORT HIGHLIGHT

Pericardiocentesis Procedures Market size was valued at USD 181.09 Million in 2023, expanding at a CAGR of 3.29% from 2024 to 2032.

Pericardiocentesis is a medical procedure used to remove excess fluid from the pericardium, the sac-like structure surrounding the heart. This fluid buildup, known as pericardial effusion, can put pressure on the heart, affecting its ability to function properly. In severe cases, it can lead to cardiac tamponade, a life-threatening condition where the heart cannot pump effectively due to the pressure.

Pericardiocentesis Procedures Market- Market Dynamics

Growing prevalence of cardiovascular disorders and rise in cancer therapies, early diagnosis is expected to propel market demand

The rising incidence of cardiovascular conditions such as pericarditis, heart failure, and pericardial effusion increases the demand for pericardiocentesis as a treatment option, which in turn is boosting market growth. Cardiac tamponade requires urgent pericardiocentesis for relief. Improved imaging technologies like ultrasound and echocardiography have made pericardiocentesis more accurate and safer, contributing to higher adoption rates. These imaging tools are essential for guiding the procedure.

Greater awareness of pericardial effusion and its complications has led to earlier detection and intervention. This, coupled with improved diagnostic capabilities, has driven the demand for procedures like pericardiocentesis. Certain cancer treatments, such as chemotherapy and radiation, can cause pericardial effusion as a side effect. This has led to increased demand for pericardiocentesis in cancer patients, especially those with advanced disease. Technological advancements in catheter-based therapies for pericardiocentesis, including improvements in needle design, catheter technology, and drainage systems, make the procedure more efficient and safer, boosting its adoption and supporting market growth.

Pericardiocentesis Procedures Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.29% over the forecast period (2024-2032)

Based on Indication segmentation, the malignancies segment was predicted to show maximum market share in the year 2023, owing to the high prevalence of cancer.

Based on Disease Type segmentation, the lung cancer segment was the leading Disease Type segment in 2023, due to the rise in cardiac disorders.

Based on End User segmentation, the hospital & clinics segment was the leading End User segment in 2023, due to the need for diagnosis of advanced cancer, tuberculosis, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the high prevalence of cardiovascular diseases.

Pericardiocentesis Procedures Market- Segmentation Analysis:

Global Pericardiocentesis Procedures Market is segmented on the basis of Indication, Disease Type, End User, and Region.

The market is divided into five categories based on Indication: infections, malignancies, cardiac, inflammatory, and others. The malignancies segment dominates the market. Increasing incidence of metastatic tumors is mainly boosting segment growth.

The market is divided into four categories based on Disease Type: lung cancer, breast cancer, lymphoma, and others. The lung cancer segment dominates the market. The increasing incidence of cardiac arrests and lung diseases are fostering market demand.

The market is divided into three categories based on End User: hospital & clinics, cardiac centers, and others. The hospital & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The prevalence of chronic immune diseases like lupus, rheumatoid arthritis, and scleroderma, etc. are fueling segment growth.

Pericardiocentesis Procedures Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, the United States and Canada are major contributors, with the U.S. leading in terms of procedural volume and innovation. Europe is another significant market, driven by the aging population and rising incidence of cardiovascular diseases. In Asia Pacific, rising awareness and early diagnosis of pericardial effusion and cardiac diseases. China, Japan, and India are the key markets in this region, contributing to the growing demand for pericardiocentesis procedures.

Pericardiocentesis Procedures Market- Competitive Landscape:

The Pericardiocentesis Procedures Market is highly competitive, driven by key players like Medtronic, Boston Scientific, BD, and Cook Medical, who focus on technological innovation and product developments. Companies are offering customized pericardiocentesis kits tailored to the specific needs of healthcare providers and patient populations, ensuring that the procedure is as effective and efficient as possible. Companies are developing next-generation catheters and drainage systems that improve the safety, precision, and comfort of pericardiocentesis procedures.

In 2022, Teleflex Incorporated introduced specialized catheters and needle systems for draining fluid from the pericardial space.

In 2022, Cook Medical announced the launch of a variety of diagnostic and interventional devices, including pericardiocentesis kits and accessories.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET KEY PLAYERS

  • Boston Scientific Corporation
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cook Medical Inc.
  • CR Bard Inc.
  • Merit Medical Systems Inc.
  • Teleflex Incorporated
  • Cardinal Health Inc.
  • Johnson & Johnson Services Inc.
  • AngioDynamics Inc.
  • Medtronic
  • Smith's Medical
  • BD
  • Edwards Lifesciences
  • Stryker Corporation
  • Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Infections
  • Malignancies
  • Cardiac
  • Inflammatory
  • Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Lung cancer
  • Breast cancer
  • Lymphoma
  • Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital & clinics
  • Cardiac centers
  • Others

GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pericardiocentesis Procedures Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pericardiocentesis Procedures Market Snippet by Indication
    • 2.1.2. Pericardiocentesis Procedures Market Snippet by Disease Type
    • 2.1.3. Pericardiocentesis Procedures Market Snippet by End User
    • 2.1.4. Pericardiocentesis Procedures Market Snippet by Country
    • 2.1.5. Pericardiocentesis Procedures Market Snippet by Region
  • 2.2. Competitive Insights

3. Pericardiocentesis Procedures Key Market Trends

  • 3.1. Pericardiocentesis Procedures Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pericardiocentesis Procedures Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pericardiocentesis Procedures Market Opportunities
  • 3.4. Pericardiocentesis Procedures Market Future Trends

4. Pericardiocentesis Procedures Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pericardiocentesis Procedures Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pericardiocentesis Procedures Market Landscape

  • 6.1. Pericardiocentesis Procedures Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pericardiocentesis Procedures Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 7.1.2. Infections
    • 7.1.3. Malignancies
    • 7.1.4. Cardiac
    • 7.1.5. Inflammatory
    • 7.1.6. Others

8. Pericardiocentesis Procedures Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 8.1.2. Lung cancer
    • 8.1.3. Breast cancer
    • 8.1.4. Lymphoma
    • 8.1.5. Others

9. Pericardiocentesis Procedures Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital & clinics
    • 9.1.3. Cardiac centers
    • 9.1.4. Others

10. Pericardiocentesis Procedures Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pericardiocentesis Procedures Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pericardiocentesis Procedures Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pericardiocentesis Procedures Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pericardiocentesis Procedures Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pericardiocentesis Procedures Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pericardiocentesis Procedures Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
    • 11.2.2. Abbott Laboratories
    • 11.2.3. B. Braun Melsungen AG
    • 11.2.4. Cook Medical Inc.
    • 11.2.5. CR Bard Inc.
    • 11.2.6. Merit Medical Systems Inc.
    • 11.2.7. Teleflex Incorporated
    • 11.2.8. Cardinal Health Inc.
    • 11.2.9. Johnson & Johnson Services Inc.
    • 11.2.10. AngioDynamics Inc.
    • 11.2.11. Medtronic
    • 11.2.12. Smith's Medical
    • 11.2.13. BD
    • 11.2.14. Edwards Lifesciences
    • 11.2.15. Stryker Corporation
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us